FRANKFURT (Reuters) – Germany’s Bayer <BAYGn.DE> said on Wednesday that the number of U.S. plaintiffs blaming its glyphosate-based weedkillers for their cancer mushroomed to 42,700 from 18,400 in July.
Third-quarter adjusted core earnings for the group rose 7.5%to 2.3 billion euros ($2.6 billion), helped by higher sales of crop protection chemicals, seeds and consumer healthcare products, it added.
(Reporting by Ludwig Burger; Editing by Tassilo Hummel)
